Drug Pipeline

Gemcitabine Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04639986 Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer… Metastatic Breast Cancer Active, Not Recruiting
NCT07445295 Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With… Metastatic Pancreatic Ductal Adenocarcinoma Not Yet Recruiting
Phase 2
NCT06241781 Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or… Adult Recruiting
NCT06492915 Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal… Pancreatic Ductal Adenocarcinoma Active, Not Recruiting
Sponsors Running Gemcitabine Injection Trials
Chipscreen Biosciences, Ltd. (2) Gilead Sciences (1) Grit Biotechnology (1)
Disease Areas
Pancreatic Cancer (2) Breast Cancer (1)
Get alerts when Gemcitabine Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free